Kris Jacobs Vacancies Kris Jacobs Kris Jacobs Loading jobs... Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Photograph by Chris Allan Press release Press release | 04 November 2021 COVID-19 As Moderna releases astronomical Q3 sales figures, MSF tells the corporation it’s high time to share the technology with WHO mRNA vaccine tech transfer Hub in South Africa 5 min Photograph by Mariana Abdalla Press release Press release | 04 November 2021 COVID-19 MSF response to first regulatory approval of first oral antiviral treatment for COVID-19, molnupiravir 2 min Newsletter Newsletter | 04 November 2021 COVID-19 No profit in a pandemic! Moderna must share COVID-19 vaccine technology now Events | 03 November 2021 COVID-19 Webinar: COVID-19 shows need to boost production of medical diagnostic tools in Asia Technical brief | 28 October 2021 COVID-19 Lessons learned and recommendations to ensure access to vaccines, medicines and diagnostics in the COVID-19 pandemic response and beyond Photo by Tracy Makhlouf/MSF Press release Press release | 27 October 2021 COVID-19 MSF responds to BioNTech’s announcement that it will establish production facilities in African countries 3 min Photo by Mariana Abdalla/MSF Press release Press release | 27 October 2021 COVID-19 License between Merck and Medicines Patent Pool for global production of promising new COVID-19 drug molnupiravir disappoints in its access limitations 4 min Photograph by Paul Odongo Research article Research article | 26 October 2021 Tropical & neglected diseases Toxicon: X: Access to antivenoms in the developing world: A multidisciplinary analysis 1 min Load More
Photograph by Chris Allan Press release Press release | 04 November 2021 COVID-19 As Moderna releases astronomical Q3 sales figures, MSF tells the corporation it’s high time to share the technology with WHO mRNA vaccine tech transfer Hub in South Africa 5 min
Photograph by Mariana Abdalla Press release Press release | 04 November 2021 COVID-19 MSF response to first regulatory approval of first oral antiviral treatment for COVID-19, molnupiravir 2 min
Newsletter Newsletter | 04 November 2021 COVID-19 No profit in a pandemic! Moderna must share COVID-19 vaccine technology now
Events | 03 November 2021 COVID-19 Webinar: COVID-19 shows need to boost production of medical diagnostic tools in Asia
Technical brief | 28 October 2021 COVID-19 Lessons learned and recommendations to ensure access to vaccines, medicines and diagnostics in the COVID-19 pandemic response and beyond
Photo by Tracy Makhlouf/MSF Press release Press release | 27 October 2021 COVID-19 MSF responds to BioNTech’s announcement that it will establish production facilities in African countries 3 min
Photo by Mariana Abdalla/MSF Press release Press release | 27 October 2021 COVID-19 License between Merck and Medicines Patent Pool for global production of promising new COVID-19 drug molnupiravir disappoints in its access limitations 4 min
Photograph by Paul Odongo Research article Research article | 26 October 2021 Tropical & neglected diseases Toxicon: X: Access to antivenoms in the developing world: A multidisciplinary analysis 1 min
